Activating Compound | Comment | Organism | Structure |
---|---|---|---|
E1A | an adenovirus type 5-based vector that contains E1A, but lacks E1B and E3, specifically enhances the promoter activity by 3.5fold, which leads to increased enzyme expression, overview | Homo sapiens |
Application | Comment | Organism |
---|---|---|
pharmacology | combining topoisomerase II targeting anticancer drug therapy with E1A vector gene therapy might increase the tumor cell sensitivity and thus the therapeutic benefit | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | transfection of TC71 cells with E1A, an adenovirus type 5-based vector that contains E1A, but lacks E1B and E3, specifically enhances sensitivity of topoisomerase IIa for anticancer drugs by up-regulating the promoter activity by 3.5fold | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
adriamycin | enzyme targeting anticancer drug, inhibits in vitro and in vivo, inhibition is 8fold increased by cell transfection with the E1A vector | Homo sapiens | |
etoposide | i.e. VP-16, enzyme targeting anticancer drug, inhibits in vitro and in vivo, inhibition is 16fold increased by cell transfection with the E1A vector | Homo sapiens | |
additional information | E1A, an adenovirus type 5-based vector that contains E1A, but lacks E1B and E3, specifically enhances sensitivity to topoisomerase IIa targeting anticancer drugs etoposide and adriamycin, but not to amsacrine and camptothecin, by up-regulating the promoter activity by 3.5fold, which also leads to increased enzyme expression, overview | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
Ewing's sarcoma cell | - |
Homo sapiens | - |
TC-71 cell | Ewing's sarcoma cell line | Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
Topoisomerase II | - |
Homo sapiens |